Fingerprint
Dive into the research topics of 'Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: Results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically